ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "adalimumab and support"

  • Abstract Number: 614 • 2016 ACR/ARHP Annual Meeting

    Canadian Study of Outcomes in Adalimumab (HUMIRA®) Patients with Support for Adherence – Results from the Companion Study

    Sebastien Gerega1, Brad Millson1, Louis Bessette2, John Marshall3, Gerald Lebovic4,5, Michael Sung1, Driss Oraichi1, Sandra Gazel6, Tania Gaetano6, Martin Latour6 and Marie-Claude Laliberté6, 1IMS Brogan, Kirkland, QC, Canada, 2Centre Hospitalier de l'Université Laval, Quebec, QC, Canada, 3Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada, 4Applied Health Research Centre, St. Michael’s Hospital, Toronto, ON, Canada, 5Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, 6AbbVie, Inc., St.Laurent, QC, Canada

    Background/Purpose:  Adalimumab (ADA) is a TNF-alpha inhibitor indicated for use in various inflammatory autoimmune diseases including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.